טוען...
Trends in Neoadjuvant Endocrine Therapy Use and Impact on Rates of Breast Conservation in Hormone Receptor Positive Breast Cancer: A National Cancer Data Base Study
BACKGROUND: ACOSOG Z1031 demonstrated that neoadjuvant endocrine therapy (NET) increased breast conserving surgery (BCS) rates for postmenopausal patients with clinical tumor stage 2–4c estrogen receptor positive breast cancer. We evaluated national trends in NET use in relation to Z1031 trial condu...
שמור ב:
| הוצא לאור ב: | Ann Surg Oncol |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5437722/ https://ncbi.nlm.nih.gov/pubmed/27663568 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-016-5585-5 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|